Method for applying an active ingredient in shower water
EP1588739A1
Composition comprising a combination of calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
EP1591143A1
Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
DE10054641A1
Use of a preparation of Cimicifuga racemosa
DE19652183C1
Treating oestrogen-dependent tumour with Cimicifuga racemosa extract
EP0789576A1
Extract of crataegus and its use
HU210351A9
Glycoproteins producable from avena sativa, process for producing them, and pharmaceutical composition containing them
DE4410594A1
Medicines from Arctostaphylos uvae-ursi
EP0543201A2
Alkoxylated phenyl and coumarin derivatives, their production and use for the manufacture of medicaments
DE4230902A1
5,6-benzo-alpha-pyrone for chronic kidney insufficiency treatment - partic effective if combined with a protein restrictive diet.
DE4205843A1
Use of alpha, alpha-diphenylacetic acid 4- (N-methyl-piperidyl) ester to influence urinary bladder tone
DE4202657A1
Pharmaceutically active composition from Tanacetum parthenium and process for their extraction and medicament produced with the pharmaceutically active composition
DE4101841A1
Use of Sabal extracts to treat breast cancer
EP0455769A1
Use of 7-oh-1,2-benzopyrone for the manufacture of a medicament for the treatment of malignant tumours in humans
EP0395851A1
Avena sativa glycoproteins, procedure for obtaining them, and their use as medicines
Use of the alpha, alpha-diphenyl-alpha (3-carboxy-propionyloxy) -acetic acid 4- (N-methylpiperidyl) ester for the treatment of hypertonic functional conditions in the bladder area
